Kollareddy Madhu, Dzubak Petr, Zheleva Daniella, Hajduch Marian
Laboratory of Experimental Medicine, Department of Pediatrics, Faculty of Medicine, Palacky University, Olomouc, Czech Republic.
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2008 Jun;152(1):27-33. doi: 10.5507/bp.2008.004.
Aurora kinases are a recently discovered family of kinases (A, B & C) consisting of highly conserved serine\threonine protein kinases found to be involved in multiple mitotic events: regulation of spindle assembly checkpoint pathway, function of centrosomes and cytoskeleton, and cytokinesis. Aberrant expression of Aurora kinases may lead to cancer. For this reason the Aurora kinases are potential targets in the treatment of cancer. In this review we discuss the biology of these kinases: structure, function, regulation and association with cancer.
A literature search.
Many of the multiple functions of mitosis are mediated by the Aurora kinases. Their aberrant expression can lead to the deregulation of cell division and cancer. For this reason, the Aurora kinases are currently one of the most interesting targets for cancer therapy. Some Aurora kinase inhibitors in the clinic have proven effectively on a wide range of tumor types. The clinical data are very encouraging and promising for development of novel class of structurally different Aurora kinase inhibitors. Hopefully the Aurora kinases will be potentially useful in drug targeted cancer treatment.
极光激酶是最近发现的一个激酶家族(A、B和C),由高度保守的丝氨酸/苏氨酸蛋白激酶组成,这些激酶参与多种有丝分裂事件:纺锤体组装检查点途径的调节、中心体和细胞骨架的功能以及胞质分裂。极光激酶的异常表达可能导致癌症。因此,极光激酶是癌症治疗的潜在靶点。在本综述中,我们讨论这些激酶的生物学特性:结构、功能、调节以及与癌症的关联。
进行文献检索。
有丝分裂的许多功能是由极光激酶介导的。它们的异常表达可导致细胞分裂失控和癌症。因此,极光激酶目前是癌症治疗中最受关注的靶点之一。临床上的一些极光激酶抑制剂已在多种肿瘤类型中显示出有效性。这些临床数据对于开发一类结构不同的新型极光激酶抑制剂非常鼓舞人心且前景广阔。有望极光激酶在药物靶向癌症治疗中发挥潜在作用。